Vectus Biosystems Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.1 |
Market Cap |
AUD7.95 M |
Shares Outstanding |
23.38 M |
Public Float |
- |
Address |
11 Primrose Avenue Rosebery New South Wales (NSW) 2018 Australia |
Employees | - |
Website | http://www.vectusbiosystems.com.au |
Updated | 07/08/2019 |
Vectus Biosystems Ltd. is a drug discovery and development company. It is developing a treatment for fibrosis and high blood pressure, which includes the treatment for diseases in the fibrotic market namely, heart, kidney and liver disease. The company was founded by Karen Duggan on December 12, 2005 and is headquartered in Rosebery, Australia. |